Sarepta Therapeutics
SRPT
#4401
Rank
โ‚น209.54 B
Marketcap
โ‚น2,000
Share price
-2.45%
Change (1 day)
-81.30%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚น313.83 Billion

According to Sarepta Therapeutics 's latest financial reports the company's total assets are โ‚น313.83 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Sarepta Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚น339.98 B25.1%
2023-12-31โ‚น271.77 B4.98%
2022-12-31โ‚น258.87 B10.48%
2021-12-31โ‚น234.30 B7.34%
2020-12-31โ‚น218.28 B67.93%
2019-12-31โ‚น129.98 B13.21%
2018-12-31โ‚น114.81 B37.48%
2017-12-31โ‚น83.51 B189.78%
2016-12-31โ‚น28.81 B58.4%
2015-12-31โ‚น18.19 B-2.7%
2014-12-31โ‚น18.69 B3.81%
2013-12-31โ‚น18.01 B60.49%
2012-12-31โ‚น11.22 B290.25%
2011-12-31โ‚น2.87 B39.6%
2010-12-31โ‚น2.06 B-26.03%
2009-12-31โ‚น2.78 B126.93%
2008-12-31โ‚น1.22 B-19.06%
2007-12-31โ‚น1.51 B-16.22%
2006-12-31โ‚น1.80 B-28.7%
2005-12-31โ‚น2.53 B105.52%
2004-12-31โ‚น1.23 B-42.46%
2003-12-31โ‚น2.14 B56.49%
2002-12-31โ‚น1.37 B-15.93%
2001-12-31โ‚น1.63 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Gilead Sciences
GILD
โ‚น5.258 T 1,575.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น105.99 B-66.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
โ‚น191.72 B-38.91%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น40.10 B-87.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น435.85 B 38.88%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
โ‚น237.50 B-24.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Insmed
INSM
โ‚น212.08 B-32.42%๐Ÿ‡บ๐Ÿ‡ธ USA